Biocon Ltd
NSE:BIOCON

Watchlist Manager
Biocon Ltd Logo
Biocon Ltd
NSE:BIOCON
Watchlist
Price: 331.5 INR 2.6% Market Closed
Market Cap: 398B INR
Have any thoughts about
Biocon Ltd?
Write Note

Intrinsic Value

The intrinsic value of one BIOCON stock under the Base Case scenario is 455.48 INR. Compared to the current market price of 331.5 INR, Biocon Ltd is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIOCON Intrinsic Value
455.48 INR
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biocon Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BIOCON cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BIOCON?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Biocon Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Biocon Ltd

Provide an overview of the primary business activities
of Biocon Ltd.

What unique competitive advantages
does Biocon Ltd hold over its rivals?

What risks and challenges
does Biocon Ltd face in the near future?

Has there been any significant insider trading activity
in Biocon Ltd recently?

Summarize the latest earnings call
of Biocon Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biocon Ltd.

Provide P/S
for Biocon Ltd.

Provide P/E
for Biocon Ltd.

Provide P/OCF
for Biocon Ltd.

Provide P/FCFE
for Biocon Ltd.

Provide P/B
for Biocon Ltd.

Provide EV/S
for Biocon Ltd.

Provide EV/GP
for Biocon Ltd.

Provide EV/EBITDA
for Biocon Ltd.

Provide EV/EBIT
for Biocon Ltd.

Provide EV/OCF
for Biocon Ltd.

Provide EV/FCFF
for Biocon Ltd.

Provide EV/IC
for Biocon Ltd.

Show me price targets
for Biocon Ltd made by professional analysts.

What are the Revenue projections
for Biocon Ltd?

How accurate were the past Revenue estimates
for Biocon Ltd?

What are the Net Income projections
for Biocon Ltd?

How accurate were the past Net Income estimates
for Biocon Ltd?

What are the EPS projections
for Biocon Ltd?

How accurate were the past EPS estimates
for Biocon Ltd?

What are the EBIT projections
for Biocon Ltd?

How accurate were the past EBIT estimates
for Biocon Ltd?

Compare the revenue forecasts
for Biocon Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biocon Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biocon Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biocon Ltd compared to its peers.

Compare the P/E ratios
of Biocon Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Biocon Ltd with its peers.

Analyze the financial leverage
of Biocon Ltd compared to its main competitors.

Show all profitability ratios
for Biocon Ltd.

Provide ROE
for Biocon Ltd.

Provide ROA
for Biocon Ltd.

Provide ROIC
for Biocon Ltd.

Provide ROCE
for Biocon Ltd.

Provide Gross Margin
for Biocon Ltd.

Provide Operating Margin
for Biocon Ltd.

Provide Net Margin
for Biocon Ltd.

Provide FCF Margin
for Biocon Ltd.

Show all solvency ratios
for Biocon Ltd.

Provide D/E Ratio
for Biocon Ltd.

Provide D/A Ratio
for Biocon Ltd.

Provide Interest Coverage Ratio
for Biocon Ltd.

Provide Altman Z-Score Ratio
for Biocon Ltd.

Provide Quick Ratio
for Biocon Ltd.

Provide Current Ratio
for Biocon Ltd.

Provide Cash Ratio
for Biocon Ltd.

What is the historical Revenue growth
over the last 5 years for Biocon Ltd?

What is the historical Net Income growth
over the last 5 years for Biocon Ltd?

What is the current Free Cash Flow
of Biocon Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biocon Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biocon Ltd

Current Assets 151.8B
Cash & Short-Term Investments 14.1B
Receivables 72.6B
Other Current Assets 65.1B
Non-Current Assets 408.9B
Long-Term Investments 7.5B
PP&E 119.8B
Intangibles 266.6B
Other Non-Current Assets 15B
Current Liabilities 153.6B
Accounts Payable 68.2B
Accrued Liabilities 4.1B
Short-Term Debt 21.5B
Other Current Liabilities 59.9B
Non-Current Liabilities 209.3B
Long-Term Debt 134.2B
Other Non-Current Liabilities 75B
Efficiency

Earnings Waterfall
Biocon Ltd

Revenue
148.9B INR
Cost of Revenue
-49.3B INR
Gross Profit
99.7B INR
Operating Expenses
-84.7B INR
Operating Income
15B INR
Other Expenses
-625m INR
Net Income
14.4B INR

Free Cash Flow Analysis
Biocon Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the second quarter of fiscal 2025, Biocon reported a 4% revenue growth and an 8% increase when adjusted for one-time revenues. The biosimilars sector thrived, showing a 19% year-on-year rise, while generics faced challenges, declining 8%. Management anticipates recovery driven by new product launches, including a GLP-1 generic expected in the UK. The total revenue reached INR 3,623 crore. Despite flat overall performance, there were signs of growth in the second half, with an EBITDA margin of 20%. Significant debt refinancing improved financial flexibility, positioning Biocon for potential expansion and growth in the next phases.

What is Earnings Call?
Fundamental Scores

BIOCON Profitability Score
Profitability Due Diligence

Biocon Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
52/100
Profitability
Score

Biocon Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

BIOCON Solvency Score
Solvency Due Diligence

Biocon Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
32/100
Solvency
Score

Biocon Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOCON Price Targets Summary
Biocon Ltd

Wall Street analysts forecast BIOCON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOCON is 344.51 INR with a low forecast of 237.35 INR and a high forecast of 483 INR.

Lowest
Price Target
237.35 INR
28% Downside
Average
Price Target
344.51 INR
4% Upside
Highest
Price Target
483 INR
46% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BIOCON?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIOCON is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BIOCON Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Biocon Ltd Logo
Biocon Ltd

Country

India

Industry

Biotechnology

Market Cap

398B INR

Dividend Yield

0.15%

Description

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. The company is headquartered in Bangalore, Karnataka and currently employs 3,203 full-time employees. The company went IPO on 2004-04-17. The firm is also focused on developing novel therapies for diabetes, oncology and immunology. The Company’s businesses segment includes Generics, Biosimilars, Novel Biologics and Research Services. The Company’s Generic Formulations and active pharmaceutical ingredients (API)products include Rosuvastatin, Simvastatin, Atorvastatin, Fingolimod, Dapagliflozin, Pemetrexed, Simvastatin, Atorvastatin, Rosuvastatin, Dabigatran, Apixaban, Vildagliptin, Linagliptin, Empagliflozin, Repaglinide, Liraglutide, Sirolimus, Pimecrolimus, Mycophenolate Mofetil (MMF), Glatiramer Acetate, Fingolimod, Teriflunomide, Dasatinib, Lenalidomide, Pazopanib, Erdafitinib Orlistat, Mirabegron, Posaconazole, Micafungin, Anidulafungin and Brinzolamide. The Company’s portfolio includes ALZUMAb-L (Itolizumab), RemWin (Remdesivir), ARAFLU (Favipiravir) and CytoSorb.

Contact

KARNATAKA
Bangalore
20th KM, Hosur Road, Electronics City
+918028082808
www.biocon.com

IPO

2004-04-17

Employees

3 203

Officers

Founder & Executive Chairperson
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc.
MD, CEO & Director
Mr. Siddharth Mittal BCom, CA, CPA
Group Chief Executive Officer
Mr. Peter James Jonathan Bains
Chief Financial Officer
Mr. Mukesh Kamath
Head of Operations
Mr. Arun Gupta
Group Chief Information Officer
Mr. Atanu Roy
Show More
Head of Investor Relations
Mr. Saurabh Paliwal
Company Secretary & Compliance Officer
Mr. Mayank Verma
Global Head of Communications & Corporate Brand
Ms. Seema Shah Ahuja BA, MBA
Head of Human Resources
Ms. Maninder Kapoor Puri
Show Less

See Also

Discover More
What is the Intrinsic Value of one BIOCON stock?

The intrinsic value of one BIOCON stock under the Base Case scenario is 455.48 INR.

Is BIOCON stock undervalued or overvalued?

Compared to the current market price of 331.5 INR, Biocon Ltd is Undervalued by 27%.

Back to Top